UNITED THERAPEUTICS Corp (UTHR) Stock Profile — Insider Trades & Financials

Revenue$790.2M

Net Income$364.3M

EPS$27.86

Gross Margin86.9%

Market Cap$24.8B

Price Performance

Historical data including institutional events

Loading price data...

Company Profile

Martine Rothblatt

CEO & Executive Director

United Therapeutics Corporation is an American biotechnology company that develops pharmaceuticals and technologies related to organ transplantation, including xenotransplantation. Many of the company's products are focused towards lung disease and organ manufacturing. United Therapeutics is co-headquartered in Silver Spring, Maryland and Research Triangle Park, North Carolina, with additional facilities in Magog and Bromont, Quebec; Melbourne and Jacksonville, Florida; Blacksburg, Virginia; and Manchester, New Hampshire.

Founded: 1996
Employees: 1,168
Headquarters: SILVER SPRING, MD, United States
Website

⚡

Core Efficiency

ROE?

5.13%

ROA?

4.62%

D/E Ratio?

0.11

Op. Margin?

45.14%

📊

Profitability Ratios

Net Margin?

46.10%

Loading company sections...

UNITED THERAPEUTICS Corp

Price Performance

Company Profile

Core Efficiency

Profitability Ratios

Core Efficiency

Profitability Ratios

Earnings Calendar

Data Freshness